Valuation: Viatris Inc.

Market Cap 18.95B 16.57B 15.29B 14.12B 26.79B 1,807B 27.24B 183B 71.73B 890B 71.14B 69.59B 3,060B P/E 2026 *
69.8x
P/E 2027 * 25.8x
Enterprise Value 31.13B 27.23B 25.12B 23.2B 44.02B 2,969B 44.76B 300B 118B 1,463B 117B 114B 5,029B EV / Sales 2026 *
2.11x
EV / Sales 2027 * 1.99x
Free-Float
92.23%
Yield 2026 *
3.13%
Yield 2027 * 3.21%
1 day-0.43%
1 week-2.57%
Current month+2.46%
1 month+3.17%
3 months+20.79%
6 months+27.51%
Current year+30.68%
1 week 15.95
Extreme 15.95
17.16
1 month 14.94
Extreme 14.94
17.16
Current year 12.19
Extreme 12.19
17.53
1 year 8.62
Extreme 8.625
17.53
3 years 6.85
Extreme 6.85
17.53
5 years 6.85
Extreme 6.85
17.53
10 years 6.85
Extreme 6.85
50.4
Manager TitleAgeSince
Chief Executive Officer 63 2023-03-31
Director of Finance/CFO 59 2026-05-07
Chief Tech/Sci/R&D Officer - 2023-12-14
Director TitleAgeSince
Director/Board Member 78 2020-11-15
Director/Board Member 78 2020-11-15
Director/Board Member 62 2020-11-15
Date Insider Type Main position Quantity % Market Cap.
06-29Free

Director

2,362 0.0002%
06-29Free

Director

2,756 0.0002%
06-24Sell

Chief Financial Officer

-50,076 0.0043%
Change 5-day change 1-year change 3-year change Capi.($)
-0.43%-2.57%+75.89%+63.85% 18.95B
-2.33%-2.09%+50.33%+162.29% 1,060B
-0.82%-2.30%+62.97%+61.11% 619B
-0.73%-4.98%+27.22%+84.46% 438B
+0.33%-1.17%+27.98%+26.90% 333B
-0.02%-2.85%+25.27%+44.88% 282B
-3.89%-11.22%+20.78%+26.07% 267B
+0.66%-1.42%-29.26%-39.30% 218B
-0.06%-2.88%+20.98%+61.70% 196B
-3.72%-1.10%+13.35%+71.53% 161B
Average -0.85%-3.18%+29.55%+56.35% 359.29B
Weighted average by Cap. -0.56%-2.95%+35.50%+81.18%

Financials

2026 *2027 *
Net sales 14.77B 12.92B 11.92B 11.01B 20.89B 1,409B 21.24B 142B 55.93B 694B 55.47B 54.27B 2,386B 15.04B 13.15B 12.13B 11.21B 21.26B 1,434B 21.62B 145B 56.93B 707B 56.46B 55.23B 2,429B
Net income 13M 11.37M 10.49M 9.69M 18.38M 1.24B 18.69M 125M 49.2M 611M 48.8M 47.74M 2.1B 498M 435M 401M 371M 703M 47.45B 715M 4.8B 1.88B 23.38B 1.87B 1.83B 80.36B
Net Debt 12.19B 10.66B 9.83B 9.08B 17.23B 1,162B 17.52B 117B 46.13B 573B 45.76B 44.76B 1,968B 11.03B 9.65B 8.9B 8.22B 15.6B 1,052B 15.86B 106B 41.76B 518B 41.42B 40.52B 1,782B
Logo Viatris Inc.
Viatris Inc. is a global healthcare company. The Company markets branded and generic drugs, including complex drugs. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Company's Greater China segment includes its operations in mainland China, Taiwan and Hong Kong. The Company's JANZ segment consists of its operations in Japan, Australia and New Zealand. Its Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company's ARV franchise. It produces medicines for patients across a broad range of major therapeutic areas. From cardiovascular health to oncology, it offers treatment options across more than 10 major therapeutic areas covering a variety of noncommunicable and infectious diseases.
Employees
30,000
Date Price Change Volume
26-07-10 US$16.27 -0.43% 7,928,551
26-07-09 US$16.34 -1.92% 9,207,660
26-07-08 US$16.66 -1.77% 8,683,561
26-07-07 US$16.96 +0.95% 9,803,415
26-07-06 US$16.80 +0.60% 11,422,070
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
16.27USD
Average target price
17.81USD
Spread / Average Target
+9.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VTRS Stock